Banks are back: a look at three stages of U.S. bank recovery

U.S. bank stocks fell dramatically in early 2020 as investors feared that economic lockdowns would severely weaken banks’ loan portfolios as COVID-19 spread across the globe. The potential for losses on a scale of those that banks sustained in the global financial crisis led investors to flee the market segment. Yet 18 months later, bank equities have proven resilient. In this commentary, we explore how U.S. banks prepared to weather the economic tail risk of a pandemic and discuss why we maintain a favorable view of the segment amid prospective signs of continued strength for banks.

Banks are back: a look at three stages of U.S. bank recovery

In the early months of COVID-19, banks built significant loan loss reserves to protect against pandemic-related losses. These reserves have proved more than adequate, in our view, and actual losses have been limited due to fiscal support as well as banks’ abilities to work with borrowers suffering business interruptions.

While we’re still working our way through another wave of COVID-19 cases driven by the Delta variant, it appears the U.S. economy has maintained its footing through the uptick in cases. From our discussions with bank management teams, we believe the Delta surge isn’t likely to lead to meaningfully higher loan losses. In fact, we think a multistage bank recovery is already under way, as signaled by recent strength in quarterly earnings. 

Stage 1: banks’ 2021 credit rebound

As the market realized that credit losses would be contained earlier this year, the first part of the recovery took hold. We call this the credit rebound. Banks’ earnings recovered from depressed levels in 2020, as they no longer needed to set aside outsized provisions for loan losses. 

U.S. bank earnings came roaring back from pandemic lows

KBW NASDAQ Bank Index quarterly earnings per share, Q1 2006 to Q2 2021 ($)

This chart shows how U.S. bank earnings per share came roaring back in late 2020 and early 2021 from their low point in the early months of the pandemic.  Prior to that, bank earnings generally rose from 2009 to 2019.
Source: Bloomberg, as of June 30, 2021. The KBW NASDAQ Bank Index tracks the performance of leading banks and thrifts that are publicly traded in the United States. It is not possible to invest directly in an index. Earnings per share (EPS) is a measure of how much profit a company has generated calculated by dividing the company's net income by its total number of outstanding shares.

 

Meanwhile, as U.S. regulators became comfortable with the safety of bank balance sheets during the pandemic, banks were permitted to increase capital returns to shareholders through the resumption of share buybacks. In addition, temporary restrictions on banks’ dividend payments were lifted.

Stage 2: improving prospects for a bank revenue rebound

While their credit prospects improved this year, banks have faced headwinds on the revenue front, driven by the lower level of absolute interest rates and muted loan demand. We think these trends should reverse as we move into 2022 and the economy continues to normalize.

Throughout the pandemic, banks have seen a surge in deposits driven by customers displaying cautionary behavior. In addition, many Americans deposited proceeds from government stimulus payments. Likewise, banks have been cautious in investing the deposit inflow into securities; therefore, cash levels on bank balance sheets have surged. Meanwhile, loan demand has been muted as borrowers flush with government transfers have had a limited appetite to borrow. On top of this, supply chain interruptions have driven down inventory levels throughout the economy, which has pressured commercial loan utilization rates.

As the economic rebound gains momentum and government stimulus programs wind down, we expect loan demand to accelerate. Management teams at many banks have recently said that internal loan pipelines have rebounded to prepandemic levels. Additionally, we expect that an inventory restocking will occur as supply chains normalize over the next year, benefiting loan demand.

A notable example of this is at automobile dealerships, where inventory levels have recently plunged.  This inventory is likely to rebound as production of new vehicles begins to normalize in 2022. 

U.S. vehicle inventories have fallen sharply amid the pandemic

Monthly domestic automobile inventories, August 2011–August 2021

This chart show how U.S. vehicle inventories have fallen sharply during the pandemic.  In the years leading up to COVID-19,  inventories rose in the 2012 to 2014 period, then bean to slip in 2017, and fell more sharply in 2020 and early 2021..

Source: U.S. Federal Reserve Bank of St. Louis, U.S. Bureau of Economic Analysis, October 2021.

 

In addition, we think that the infrastructure legislation that the Biden administration is now trying to push through Congress is likely to drive loan demand for years to come as contractors and suppliers will need to invest to support their capital needs.

Two other factors are important for investors to note. We believe that a potential uptick in lending would drive net interest income higher, fueling the revenue rebound, while a more normalized interest-rate environment would provide an additional catalyst.  

At its September 2021 meeting, the U.S. Federal Reserve indicated that it’s likely to begin tapering its bond-buying stimulus activity in the months ahead. We believe such a move would benefit banks, as they could invest some of their excess cash into loans and securities generating higher interest rates. 

Stage 3: bank efficiency improvement

Following the credit and revenue rebounds, we believe the final stage of the banking sector’s recovery will be driven by efficiency improvement. Banks have improved their operational efficiency over the past two decades, and we believe this trend is likely to persist—and even accelerate—as we continue to move past the pandemic. 

U.S. banks: two decades of efficiency gains have kept a lid on noninterest expenses

U.S. banks' quarterly total noninterest expenses as a percentage of total assets,  Q1 2001–Q2 2021

This chart shows two decades of efficiency gains for U.S. banks have helped them to keep a lid on non-interest expenses, which generally fell from 2001  through 2019 and began to fall at a faster rate 2020 with the start of the pandemic.
Source: Federal Deposit Insurance Corp., as of  July 2021.

During the pandemic, banks’ advanced technology adoption accelerated significantly. With branch lobbies closed for extended periods, customers who previously made in-person visits were directed to mobile delivery methods, accelerating digital adoption. Additionally, with the government’s rapid roll out of the Paycheck Protection Program, many banks used new technologies to fast-track commercial loan origination. Finally, banks continue to invest in back-office technologies, such as robotic process automation, to streamline workflows. We think this will continue, and it’s likely that banks will seek to cut more costs and close more branches in the years ahead.

Aside from technological advancements, another driver of efficiency improvement for the industry has been the long-term trend of consolidation. Following a pause during the height of the pandemic, merger and acquisition (M&A) activity has surged. In fact, through the first eight months of 2021, we’ve already seen 18 bank deals in excess of $500 million in value each. According to S&P Capital IQ, this is the highest number of deals of this value since 1998, when 24 such deals were announced.1

In many of these deals, the acquiring bank can often eliminate upward of 30% of the acquired institution’s cost base, in our experience; these significant operating efficiencies typically drive earnings accretion for the acquirer. With nearly 5,000 banks remaining in the United States,2 we see a long runway for M&A to continue—and to continue creating compelling investment opportunities.

Expect further support for bank fundamentals

We believe that continued economic recovery from the pandemic downturn clearly will support banks’ fundamentals and earnings going forward. For investors, the banking sector still provides an attractive opportunity as bank shares remain discounted relative to historical averages and to the broader indexes, in our view.

Bank stocks were trading at 1.28x their book value as of September 30, 2021, a meaningful discount to their long-term average of 1.61x dating to the mid-1990s.3 We’d note that despite the significant pandemic headwinds in 2020, the industry remained profitable overall that year and grew book value. Book value growth accelerated in the first half of 2021 as well, on the back of lower provisioning requirements, and we think this is likely to extend into 2022.

Moreover, on a relative basis, banks recently traded at about 63% of the forward price-to-earnings ratio of the broader market.4 Additionally, we believe there is upside potential to earnings estimates if the economy continues to improve given the revenue rebound through higher loan growth and higher rates in the years ahead. Taken together, these trends bode well for the prospects of bank shares.

 

1 “Wave of large-scale US bank M&A reaches highest level in 23 years,” S&P Capital IQ, September 27, 2021. 2 Federal Deposit Insurance Corp., as of June 30, 2021. 3 FactSet, as of September 30, 2021, for the S&P Composite 1500 Banks Index relative to its average dating to December 31, 1994. The S&P Composite 1500 Banks Index tracks the performance of publicly traded large- and mid-cap banking companies in the United States. It is not possible to invest directly in an index. 4 FactSet, as of September 30, 2021. The 63% figure represents a forward price-to-earnings ratio of 12.58x for the S&P Composite 1500 Banks Index and 20.12x for S&P 500 Index. The S&P Composite 1500 Banks Index tracks the performance of publicly traded large- and mid-cap banking companies in the United States. The S&P 500 Index tracks the performance of 500 of the largest publicly traded companies in the United States. It is not possible to invest directly in an index.

A widespread health crisis such as a global pandemic could cause substantial market volatility, exchange-trading suspensions and closures, and affect portfolio performance. For example, the novel coronavirus disease (COVID-19) has resulted in significant disruptions to global business activity. The impact of a health crisis and other epidemics and pandemics that may arise in the future, could affect the global economy in ways that cannot necessarily be foreseen at the present time. A health crisis may exacerbate other pre-existing political, social and economic risks. Any such impact could adversely affect the portfolio’s performance, resulting in losses to your investment

Investing involves risks, including the potential loss of principal. Financial markets are volatile and can fluctuate significantly in response to company, industry, political, regulatory, market, or economic developments.  These risks are magnified for investments made in emerging markets. Currency risk is the risk that fluctuations in exchange rates may adversely affect the value of a portfolio’s investments.

The information provided does not take into account the suitability, investment objectives, financial situation, or particular needs of any specific person. You should consider the suitability of any type of investment for your circumstances and, if necessary, seek professional advice.

This material is intended for the exclusive use of recipients in jurisdictions who are allowed to receive the material under their applicable law. The opinions expressed are those of the author(s) and are subject to change without notice. Our investment teams may hold different views and make different investment decisions. These opinions may not necessarily reflect the views of Manulife Investment Management or its affiliates. The information and/or analysis contained in this material has been compiled or arrived at from sources believed to be reliable, but Manulife Investment Management does not make any representation as to their accuracy, correctness, usefulness, or completeness and does not accept liability for any loss arising from the use of the information and/or analysis contained. The information in this material may contain projections or other forward-looking statements regarding future events, targets, management discipline, or other expectations, and is only current as of the date indicated. The information in this document, including statements concerning financial market trends, are based on current market conditions, which will fluctuate and may be superseded by subsequent market events or for other reasons. Manulife Investment Management disclaims any responsibility to update such information.

Neither Manulife Investment Management or its affiliates, nor any of their directors, officers or employees shall assume any liability or responsibility for any direct or indirect loss or damage or any other consequence of any person acting or not acting in reliance on the information contained here.  All overviews and commentary are intended to be general in nature and for current interest. While helpful, these overviews are no substitute for professional tax, investment or legal advice. Clients should seek professional advice for their particular situation. Neither Manulife, Manulife Investment Management, nor any of their affiliates or representatives is providing tax, investment or legal advice.  This material was prepared solely for informational purposes, does not constitute a recommendation, professional advice, an offer or an invitation by or on behalf of Manulife Investment Management to any person to buy or sell any security or adopt any investment strategy, and is no indication of trading intent in any fund or account managed by Manulife Investment Management. No investment strategy or risk management technique can guarantee returns or eliminate risk in any market environment. Diversification or asset allocation does not guarantee a profit or protect against the risk of loss in any market. Unless otherwise specified, all data is sourced from Manulife Investment Management. Past performance does not guarantee future results.

Manulife Investment Management

Manulife Investment Management is the global wealth and asset management segment of Manulife Financial Corporation. We draw on more than a century of financial stewardship to partner with clients across our institutional, retail, and retirement businesses globally. Our specialist approach to money management includes the highly differentiated strategies of our fixed-income, specialized equity, multi-asset solutions, and private markets teams—along with access to specialized, unaffiliated asset managers from around the world through our multimanager model.

This material has not been reviewed by, is not registered with any securities or other regulatory authority, and may, where appropriate, be distributed by the following Manulife entities in their respective jurisdictions. Additional information about Manulife Investment Management may be found at manulifeim.com/institutional

Australia: Hancock Natural Resource Group Australasia Pty Limited., Manulife Investment Management (Hong Kong) Limited. Brazil: Hancock Asset Management Brasil Ltda. Canada: Manulife Investment Management Limited, Manulife Investment Management Distributors Inc., Manulife Investment Management (North America) Limited, Manulife Investment Management Private Markets (Canada) Corp. China: Manulife Overseas Investment Fund Management (Shanghai) Limited Company. European Economic Area Manulife Investment Management (Ireland) Ltd. which is authorised and regulated by the Central Bank of Ireland Hong Kong: Manulife Investment Management (Hong Kong) Limited. Indonesia: PT Manulife Aset Manajemen Indonesia. Japan: Manulife Investment Management (Japan) Limited. Malaysia: Manulife Investment Management (M) Berhad  200801033087 (834424-U) Philippines: Manulife Investment Management and Trust Corporation. Singapore: Manulife Investment Management (Singapore) Pte. Ltd. (Company Registration No. 200709952G) South Korea: Manulife Investment Management (Hong Kong) Limited. Switzerland: Manulife IM (Switzerland) LLC. Taiwan: Manulife Investment Management (Taiwan) Co. Ltd. United Kingdom: Manulife Investment Management (Europe) Ltd. which is authorised and regulated by the Financial Conduct Authority United States: John Hancock Investment Management LLC, Manulife Investment Management (US) LLC, Manulife Investment Management Private Markets (US) LLC and Hancock Natural Resource Group, Inc. Vietnam: Manulife Investment Fund Management (Vietnam) Company Limited.

Manulife, Manulife Investment Management, Stylized M Design, and Manulife Investment Management & Stylized M Design are trademarks of The Manufacturers Life Insurance Company and are used by it, and by its affiliates under license.

PPM544043

Ryan P. Lentell, CFA

Ryan P. Lentell, CFA, 

Portfolio Manager, Capital Appreciation

Manulife Investment Management

Read bio
Susan A. Curry

Susan A. Curry, 

Senior Portfolio Manager, Capital Appreciation

Manulife Investment Management

Read bio